There were 371 press releases posted in the last 24 hours and 220,247 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image